Trump admin pursuing deals in range of industries, Reuters reports

Pharmaceutical executives are getting almost daily calls from White House Staff and senior figures at agencies such as the Commerce Department, Dawn Kopecki, Jarrett Renshaw, Ernest Scheyder and Sabrina Valle of Reuters reports, citing two sources familiar with the matter. During these calls, the White House asked Eli Lilly (LLY) to produce more insulin, Pfizer (PFE) to sell more of its cancer drug Ibrance and cholesterol drug Lipitor, and AstraZeneca (AZN) to consider a new headquarters in the U.S., the two sources added. Additionally, the Trump administration is pursuing deals in up to 30 industries, with the fast-paced dealmaking meant to deliver political wins for the president before the 2026 midterm elections, the sources added.